Author:
Kotrbová Lucie,Lara Ana Catalina,Corretto Erika,Scharfen Josef,Ulmann Vít,Petříčková Kateřina,Chroňáková Alica
Abstract
AbstractNotwithstanding the fact that streptomycetes are overlooked in clinical laboratories, studies describing their occurrence in disease and potential pathogenicity are emerging. Information on their species diversity in clinical specimens, aetiology and appropriate therapeutic treatment is scarce. We identified and evaluated the antibiotic susceptibility profile of 84 Streptomyces clinical isolates from the Czech Republic. In the absence of appropriate disk diffusion (DD) breakpoints for antibiotic susceptibility testing (AST) of Streptomyces spp., we determined DD breakpoints by correlation with the broth microdilution method and by the distribution of zone diameters among isolates. Correlation accuracy was high for 9 antibiotics, leading to the establishment of the most valid DD breakpoints for Streptomyces antibiotic susceptibility evaluation so far. Clinical strains belonged to 17 different phylotypes dominated by a cluster of strains sharing the same percentage of 16S rRNA gene sequence identity with more than one species (S. albidoflavus group, S. hydrogenans, S. resistomycificus, S. griseochromogenes; 70% of isolates). AST results showed that Streptomyces exhibited intrinsic resistance to penicillin, general susceptibility to amikacin, gentamycin, vancomycin and linezolid, and high percentage of susceptibility to tetracyclines and clarithromycin. For the remaining antibiotics, AST showed inter- and intra-species variations when compared to available literature (erythromycin, trimethoprim-sulfamethoxazole), indicating a region-dependent rather than species-specific patterns.
Funder
Academy of Sciences of the Czech Republic Strategy AV21
Ministry of Healthcare of the Czech Republic
Publisher
Springer Science and Business Media LLC
Reference71 articles.
1. Chander, J., Singla, N. & Handa, U. Human cervicofacial mycetoma caused by Streptomyces griseus: First case report. J. Microbiol. Immunol. Infect. 48, 703–705 (2015).
2. Borelli, D. & Middelveen, M. Actinomycetoma Caused by Streptomyces somaliensis. Arch. Dermatol. 122, 1097–1098 (1986).
3. Chaudhuri, B. N., Maiti, P. K. & Sil, J. Antibiotic sensitivity patterns of actinomycetes isolated from patients of actinomycetoma. Indian J. Med. Res. 105, 162–166 (1997).
4. Quintana, E. T. et al. Streptomyces sudanensis sp. nov., a new pathogen isolated from patients with actinomycetoma. Antonie Van Leeuwenhoek 93, 305–313 (2008).
5. Joseph, N. M., Harish, B. N., Sistla, S., Thappa, D. M. & Parija, S. C. Streptomyces bacteremia in a patient with actinomycotic mycetoma. J. Infect. Dev. Ctries. 4, 249–252 (2010).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献